ECELLFRANCE is the French Research Infrastructure for mesenchymal stem cell (MSC)-based therapies.
Since its creation in 2012, it has been involved in over 20 national and European research & innovation programs in cell-based therapy.
It brings together :
In the fields of :
ECELLFRANCE is open to academics and industrials requesting support for their pre-clinical and/or clinical programs in the field of cell-based therapies. The infrastructure provides services covering the entire MSC-based production and development pipeline including:
|- Project validation||- Production of ATMP||- Immunomonitoring|
|- Preclinical studies||
- Safety and potency tests
- Regulatory support
- Phase I and II clinical trials
Service requests can be submitted by filling the application form.